NCT06049654View on ClinicalTrials.gov

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

NARecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Aortic Valve StenosisStructural Valve Deterioration
Interventions
DEVICE

NVT ALLEGRA TAVI System TF

Transcatheter aortic valve implantation of a NVT ALLEGRA TAVI System TF in patients with severe haemodynamical valve deterioration of a biological aortic valve implanted surgically

DEVICE

EDWARDS SAPIEN 3 or SAPIEN ULTRA SYSTEM

Transcatheter aortic valve implantation of an EDWARDS SAPIEN 3 SYSTEM in patients with severe haemodynamical valve deterioration of a biological aortic valve implanted surgically

Trial Locations (9)

28040

RECRUITING

Hospital Clinico San Carlos, Madrid

28046

RECRUITING

Hospital Universitario de La Paz, Madrid

28222

RECRUITING

Hospital Universitario Puerta De Hierro, Majadahonda

37007

RECRUITING

Hospital Clínico Universitario de Salamanca, Salamanca

46026

RECRUITING

Hospital Universitari I Politècnic de La Fe, Valencia

08907

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

Unknown

RECRUITING

Manchester University NHS Foundation Trust, Manchester

RECRUITING

Freeman Hospital, Newcastle

RECRUITING

Morriston Hospital, Swansea, Swansea

All Listed Sponsors
lead

Fundación EPIC

OTHER